BetterLife Pharma Inc. Files April 2024 6-K Report
Ticker: BETRF · Form: 6-K · Filed: Apr 4, 2024 · CIK: 1464165
| Field | Detail |
|---|---|
| Company | Betterlife Pharma INC. (BETRF) |
| Form Type | 6-K |
| Filed Date | Apr 4, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, regulatory-filing, foreign-private-issuer
TL;DR
BetterLife Pharma (BETRF) filed its April 6-K, standard foreign issuer report. Nothing major, just compliance.
AI Summary
BetterLife Pharma Inc. filed a Form 6-K on April 4, 2024, reporting for the month of April 2024. The company, formerly known as Pivot Pharmaceuticals Inc. and Neurokine Pharmaceuticals Inc., is based in Vancouver, BC, and operates in the Pharmaceutical Preparations sector. This filing is a routine report for foreign private issuers.
Why It Matters
This filing provides an update on BetterLife Pharma's regulatory reporting status as a foreign private issuer, which is important for investors tracking their compliance and disclosures.
Risk Assessment
Risk Level: low — This filing is a routine operational report and does not contain significant new financial or strategic information that would immediately impact the company's risk profile.
Key Players & Entities
- BetterLife Pharma Inc. (company) — Registrant
- Pivot Pharmaceuticals Inc. (company) — Former company name
- Neurokine Pharmaceuticals Inc. (company) — Former company name
- Vancouver, BC (location) — Company headquarters
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, providing information that the registrant makes or is required to make public pursuant to the laws of its home country.
When was BetterLife Pharma Inc. formerly known as Pivot Pharmaceuticals Inc. and Neurokine Pharmaceuticals Inc.?
BetterLife Pharma Inc. was formerly known as Pivot Pharmaceuticals Inc. after a name change on April 17, 2015, and prior to that, it was known as Neurokine Pharmaceuticals Inc. after a name change on May 14, 2009.
What is BetterLife Pharma Inc.'s Standard Industrial Classification (SIC) code?
BetterLife Pharma Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Does BetterLife Pharma Inc. file annual reports under Form 20-F or Form 40-F?
The filing indicates that BetterLife Pharma Inc. files annual reports under Form 20-F.
What is the business address of BetterLife Pharma Inc.?
The business address of BetterLife Pharma Inc. is 1275 West 6th Avenue, Vancouver, BC V6H 1A6.
Filing Stats: 344 words · 1 min read · ~1 pages · Grade level 14.9 · Accepted 2024-04-04 16:41:16
Filing Documents
- betrf_6k.htm (6-K) — 10KB
- betrf_ex991.htm (EX-99.1) — 23KB
- betrf_ex991img1.jpg (GRAPHIC) — 4KB
- 0001477932-24-001877.txt ( ) — 40KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934 , the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BETTERLIFE PHARMA INC. Date: April 4, 2024 By: /s/ Moira Ong Name: Moira Ong Title: Chief Financial Officer 3